The effect of a clinical pharmacist discharge service on medication discrepancies in patients with heart failure
Open Access
- 1 September 2010
- journal article
- research article
- Published by Springer Nature in Pharmacy World & Science
- Vol. 32 (6) , 759-766
- https://doi.org/10.1007/s11096-010-9433-6
Abstract
Objective Heart failure patients are regularly admitted to hospital and frequently use multiple medication. Besides intentional changes in pharmacotherapy, unintentional changes may occur during hospitalisation. The aim of this study was to investigate the effect of a clinical pharmacist discharge service on medication discrepancies and prescription errors in patients with heart failure. Setting A general teaching hospital in Tilburg, the Netherlands. Method An open randomized intervention study was performed comparing an intervention group, with a control group receiving regular care by doctors and nurses. The clinical pharmacist discharge service consisted of review of discharge medication, communicating prescribing errors with the cardiologist, giving patients information, preparation of a written overview of the discharge medication and communication to both the community pharmacist and the general practitioner about this medication. Within 6 weeks after discharge all patients were routinely scheduled to visit the outpatient clinic and medication discrepancies were measured. Main outcome measure The primary endpoint was the frequency of prescription errors in the discharge medication and medication discrepancies after discharge combined. Results Forty-four patients were included in the control group and 41 in the intervention group. Sixty-eight percent of patients in the control group had at least one discrepancy or prescription error against 39% in the intervention group (RR 0.57 (95% CI 0.37–0.88)). The percentage of medications with a discrepancy or prescription error in the control group was 14.6% and in the intervention group it was 6.1% (RR 0.42 (95% CI 0.27–0.66)). Conclusion This clinical pharmacist discharge service significantly reduces the risk of discrepancies and prescription errors in medication of patients with heart failure in the 1st month after discharge.Keywords
This publication has 28 references indexed in Scilit:
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)European Heart Journal, 2008
- Reliability of the assessment of preventable adverse drug events in daily clinical practicePharmacoepidemiology and Drug Safety, 2008
- Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trialBMJ, 2007
- Deficits in Communication and Information Transfer Between Hospital-Based and Primary Care PhysiciansJAMA, 2007
- Reconcilable differences: correcting medication errors at hospital admission and dischargeQuality and Safety in Health Care, 2006
- Posthospital Medication DiscrepanciesArchives of internal medicine (1960), 2005
- Comprehensive Discharge Planning With Postdischarge Support for Older Patients With Congestive Heart FailureJAMA, 2004
- Reducing Adverse Prescribing Discrepancies Following Hospital DischargeInternational Journal of Pharmacy Practice, 1998
- A chronic disease score from automated pharmacy dataJournal of Clinical Epidemiology, 1992
- The adverse effects of hospitalization on drug regimensArchives of internal medicine (1960), 1991